Previous 10 | Next 10 |
2023-09-14 16:24:06 ET More on DURECT Seeking Alpha’s Quant Rating on DURECT Historical earnings data for DURECT Financial information for DURECT DURECT Corporation ( DRRX ) Q2 2023 Earnings Call Transcript Durect stock plummets 31% on sell...
DURECT Corporation Announces Last Patient Last Visit in Phase 2b AHFIRM Trial of Larsucosterol in Alcohol-Associated Hepatitis PR Newswire Company on track to report topline data from AHFIRM in Q4 2023 CUPERTINO, Calif. , Sept. 7, 2023 /PRNewswire/ -- DU...
DURECT Corporation Announces Presentations in Upcoming Investor Conferences PR Newswire CUPERTINO, Calif. , Aug. 31, 2023 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX), a biopharmaceutical company committed to transforming the treatment of acute organ i...
2023-08-09 16:26:30 ET DURECT press release ( NASDAQ: DRRX ): Q2 GAAP EPS of -$0.46 beats by $0.02 . Revenue of $2.08M (flat Y/Y) misses by $1.08M . For further details see: DURECT GAAP EPS of -$0.46 beats by $0.02, revenue of $2.08M misses by $1.08M
DURECT Corporation Reports Second Quarter 2023 Financial Results and Business Update PR Newswire - Webcast of Earnings Call Today, August 9th at 4:30 p.m. ET - Topline data from AHFIRM trial expected in Q4 2023 CUPERT...
DURECT Corporation to Announce Second Quarter 2023 Financial Results and Provide a Business Update PR Newswire CUPERTINO, Calif. , Aug. 3, 2023 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX), a biopharmaceutical company committed to transforming the treat...
2023-07-24 07:21:05 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips We’re starting off the week with a breakdown of the biggest pre-market stock movers for Monday morning! Moving stocks this morning are an earnings report, delisting notice, bankruptc...
2023-07-20 14:14:02 ET DURECT ( NASDAQ: DRRX ) stock price plunges 31% as it entered into definitive agreements for the purchase and sale of an aggregate of 2.99M shares of common stock and warrants to purchase up to 2.99M shares of common stock in a registered direct offe...
2023-07-20 10:23:14 ET Gainers: PainReform ( PRFX ) +55% . T2 Biosystems ( TTOO ) +19% . Inotiv ( NOTV ) +15% . Tarsus Pharmaceuticals ( TARS ) +14% . Nanobiotix ( NBTX ) +11% . Losers: Vir Biotechnology ( VIR ) ...
2023-07-20 08:29:22 ET Netcapital NCPL -42% on $1.2M equity offering . Gossamer Bio ( GOSS ) -21% announces $212 Million private placement financing . DURECT Corporation ( DRRX ) -19% announces $15 Million Registered Direct Offering . Jianzhi Ed...
News, Short Squeeze, Breakout and More Instantly...
DURECT Corporation Receives FDA Breakthrough Therapy Designation for Larsucosterol in Alcohol-Associated Hepatitis PR Newswire DURECT plans to confirm the efficacy and safety of larsucosterol in a registrational Phase 3 clinical trial CUPERTINO, Calif. , May ...
A look at the top 10 most actives in the United States Faraday Future Intelligent Electric Inc. (FFIE) rose 171.6% to $0.1657 on volume of 180,907,472 shares AMC Entertainment Holdings Inc. Class A (AMC) rose 84.4% to $9.57 on volume of 174,658,682 shares Plug Power Inc. (PLUG) rose 45.9%...
DURECT Corporation Reports First Quarter 2024 Financial Results and Business Update PR Newswire - FDA Feedback Supports Single Pivotal Trial for Approval of Larsucosterol in Alcohol-Associated Hepatitis - Webcast of Ea...